Omega Healthcare Investors (BSP:O2HI34) Short-Term Debt: R$2,223 Mil (As of Mar. 2026)


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$60.64
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Short-Term Debt?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Short-Term Debt is R$2,223 Mil as of Mar. 2026. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$60.64 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Omega Healthcare Investors's Short-Term Debt for the quarter that ended in Mar. 2026 was R$2,223 Mil.

Omega Healthcare Investors's quarterly Short-Term Debt increased from Sep. 2025 (R$0 Mil) to Dec. 2025 (R$1,320 Mil) and increased from Dec. 2025 (R$1,320 Mil) to Mar. 2026 (R$2,223 Mil).

Omega Healthcare Investors's annual Short-Term Debt declined from Dec. 2023 (R$100 Mil) to Dec. 2024 (R$0 Mil) but then increased from Dec. 2024 (R$0 Mil) to Dec. 2025 (R$1,320 Mil).

Omega Healthcare Investors Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Omega Healthcare Investors Short-Term Debt Related Terms

Omega Healthcare Investors Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Short-Term Debt Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 100.95 99.94 0.00 1,320.28

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1,320.28 2,222.58
BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of R$2,223 Mil mean?
Omega Healthcare Investors (BSP:O2HI34) has a Short-Term Debt of R$2,223 Mil as of Mar. 2026.
Is Omega Healthcare Investors' Short-Term Debt too high?
Omega Healthcare Investors' current Short-Term Debt is R$2,223 Mil. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Short-Term Debt compare to DOC and AHR?
Omega Healthcare Investors' Short-Term Debt of R$2,223 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a REITs company?
A good Short-Term Debt depends on the REITs industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Omega Healthcare Investors's current Short-Term Debt is R$2,223 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Short-Term Debt is R$2,223 Mil. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Short-Term Debt is R$2,223 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Short-Term Debt: R$2,223 Mil
  • GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$60.64
GF Value